Amoxycilin-Clavilunate

# Amoxicillin-Clavulanate (Augmentin) ## Overview - **Classification**: Beta-lactam antibiotic combination; Amoxicillin is an aminopenicillin. - **Mechanism**: Amoxicillin inhibits bacterial cell wall synthesis (bactericidal). Clavulanate irreversibly inhibits beta-lactamase enzymes, protecting amoxicillin from degradation. ## Primary Indications 1. **Acute Otitis Media (AOM)** - Especially refractory cases or in high-risk patients. 2. **Community-Acquired Pneumonia (CAP)** - Used for suspected atypical or drug-resistant pathogens. 3. **Sinusitis** - Used for acute bacterial sinusitis. 4. **Skin/Soft Tissue Infections** - Including animal/human bites (E.g., *Pasteurella* spp.). ## Adult Dosing ### Standard Dosing (Based on Amoxicillin Component) **Standard Infections (e.g., Sinusitis, Skin/Soft Tissue)** - **Dose**: **500 mg** (Amox) / 125 mg (Clavulanate) - **Frequency**: Every 8 hours (TID) - **Route**: Oral **High-Dose Infections (e.g., Severe CAP, AOM)** - **Dose**: **875 mg** (Amox) / 125 mg (Clavulanate) - **Frequency**: Every 12 hours (BID) - **Route**: Oral - **Maximum Daily Amox Dose**: **4000 mg** ### Dose Adjustments - **Renal Impairment (CrCl 30-49 mL/min)**: Dosing interval every 12 hours. Do not use 875 mg or ER formulations. - **Renal Impairment (CrCl 10-29 mL/min)**: Dosing interval every 12-24 hours. Use 250 mg or 500 mg formulations only. - **Renal Impairment (CrCl <10 mL/min)**: Dosing interval every 24 hours. - **Hemodialysis**: Dose after dialysis is complete. Supplement dose. - **Hepatic Impairment**: Caution advised; monitor liver function tests (LFTs). Reduce dose if hepatic impairment is severe. - **Elderly Patients**: Adjust dose based on renal function (monitor CrCl). ## Pediatric Dosing (Based on Amoxicillin Component) Pediatric dosing uses the standard formulation (e.g., 200 mg/5 mL or 400 mg/5 mL), focusing on **weight-based dosing**. ### Neonates (0-28 days) - **Avoid use** due to immature renal function and potential risk of gut inflammation. Use amoxicillin alone or alternative agents if possible. ### Infants (1-12 months) - **Dose (Standard)**: **25 mg/kg/day** (Amox) divided every 12 hours. - **Dose (High-Dose AOM)**: **90 mg/kg/day** (Amox) divided every 12 hours. - **Formulation**: Oral suspension, concentration specific (e.g., 200/28.5 mg/5 mL). - **Maximum**: Do not exceed adult maximum daily dose. ### Children (1-12 years) - **Dose (Standard)**: **25 mg/kg/day** (Amox) divided every 12 hours. - **Dose (High-Dose AOM / Sinusitis)**: **90 mg/kg/day** (Amox) divided every 12 hours. - **Maximum Total Daily Dose**: **4000 mg** (Amox component). - **Key Safety Point**: Use formulations with the lowest clavulanate concentration (e.g., 600 mg Amox / 42.9 mg Clav per 5 mL) for high-dose regimens to reduce diarrhea risk. ### Adolescents (13-18 years) - **Dose**: Use standard **adult dosing** (500 mg TID or 875 mg BID). - **Maximum**: **4000 mg amoxicillin** per day. ## Safety Information ### Contraindications - **Absolute**: History of **hypersensitivity** reaction (anaphylaxis) to any penicillin. - **Absolute**: History of **cholestatic jaundice** or hepatic dysfunction associated with previous use. - **Relative**: Patients with confirmed infectious mononucleosis (high risk of developing non-allergic rash). ### Common Adverse Effects - **Very Common (>10%)**: Diarrhea (due to clavulanate), Nausea. - **Common (1-10%)**: Vomiting, rash (especially children), muco-cutaneous candidiasis. - **Serious but Rare**: **Clostridium difficile-associated diarrhea (CDAD)**, **severe hepatotoxicity** (often cholestatic and delayed), Stevens-Johnson Syndrome (SJS). ### Key Drug Interactions - **Warfarin**: May rarely increase INR via effects on gut flora. **Monitor INR** closely upon initiation or discontinuation. - **Allopurinol**: Increased incidence of rash (non-allergic). Avoid concurrent use if possible. - **Methotrexate**: Amoxicillin may decrease renal clearance of methotrexate. May lead to **increased toxicity**; monitor closely. ## Monitoring & Follow-up - **Before Treatment**: Assess baseline renal function (CrCl) and history of penicillin allergy. - **During Treatment**: Monitor for signs of severe diarrhea (CDAD) or rash. - **Clinical Signs**: Monitor for dark urine, yellowing of skin/eyes (jaundice), or persistent abdominal pain (signs of hepatotoxicity). - **Long-Term Use**: Check LFTs and CBC for courses exceeding 2 weeks. ## Clinical Pearls - 💡 **Tip 1**: Choose the **high-dose formulation (90 mg/kg/day)** for confirmed or strongly suspected AOM in resistant areas. - 💡 **Tip 2**: Advise patients to take with a meal or snack to minimize gastrointestinal upset (nausea, diarrhea). - 💡 **Tip 3**: If liquid suspension is prescribed, must be **refrigerated** after reconstitution and discarded after 10 days. > **⚠️ Important**: This information is for educational purposes only. Always consult current prescribing information, local guidelines, and clinical judgment before prescribing.